Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A).

Journal Article

Full Text

Duke Authors

Cited Authors

  • Nixon, A; Starr, M; Pang, H; Bulusu, A; Honeycutt, W; Amara, A; Bendell, JC; Hurwitz, H

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • e21009 - e21009

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.e21009